NCT01851473View on ClinicalTrials.gov

Interactions Between Intravenous Cocaine and Acetazolamide or Quinine

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 24, 2012

Primary Completion Date

October 7, 2015

Study Completion Date

October 7, 2015

Conditions
Cocaine UsePharmacokinetics
Interventions
DRUG

cocaine

25 mg IV on days 1, 5, and 10

DRUG

quinine

80 mg orally on days 7-10

DRUG

acetazolamide

15 mg orally on days 2-5

Trial Locations (1)

21224

National Institute on Drug Abuse, Baltimore

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT01851473 - Interactions Between Intravenous Cocaine and Acetazolamide or Quinine | Biotech Hunter | Biotech Hunter